Recent Articles from Investor Brand Network

Investor Brand Network (IBN) is a dynamic financial news and publishing company headquartered in Los Angeles, California, dedicated to enhancing corporate communications for over 500 public and private client partners across various industries. Established over 19 years ago, IBN has cultivated a portfolio of more than 70 specialized brands, amassing a collective audience of millions of social media followers, and leverages this reach to provide innovative solutions such as InvestorWire for wire-grade dissemination, article syndication to over 5,000 news outlets, and enhanced press release services.

InvestorNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Advances Its Vision for Institutional Digital Finance
MindWave Innovations (NYSE American: APUS) is positioning itself as an infrastructure provider for institutional digital finance through an interconnected blockchain ecosystem built around MindChain, its NILA digital asset, MindWaveDAO and a network of Subnets. Rather than focusing solely on cryptocurrency, the company’s strategy emphasizes the infrastructure needed to support institutional participation, including validator operations, blockchain scalability, governance, staking and digital-asset activity. MindChain serves as the foundation for the ecosystem, while NILA provides its digital-asset component, MindWaveDAO supports governance and participation, and Subnets are intended to create additional environments for network expansion. Together, these initiatives reflect MindWave’s effort to develop an integrated digital-finance platform.
Via Investor Brand Network · September 11, 2026
TechMediaBreaks – HWAL Inc. (HWAL) Bridges Music History, Digital Royalties and the Future of Entertainment
HWAL (OTCID: HWAL) is positioning itself at the intersection of music preservation, intellectual property, and emerging digital entertainment, using its Melody Trust subsidiary and Lunar Records joint venture to manage and expand a catalog of master recordings tied to artists including Ray Charles, Aretha Franklin, Elvis Presley, Dolly Parton, James Brown, and the Jackson 5. The company’s strategy goes beyond traditional licensing, emphasizing preservation, royalty management, new artist development, merchandising, and digital distribution, while also exploring blockchain-based structures for music royalties. HWAL’s music catalog and related intellectual property were independently valued at approximately $480 million according to the company’s latest quarterly disclosure. Its partnership with SI Blue Foundation (SpaceBlue) also links the company to the Lunaprise Museum, a lunar archive carrying hundreds of songs and artworks, highlighting HWAL’s broader vision of preserving and monetizing entertainment assets across both traditional and emerging platforms.
Via Investor Brand Network · September 11, 2026
TechMediaBreaks – D-Wave Quantum Inc. (NASDAQ: QBTS) Finalizes Definitive Agreement with U.S. Department of Commerce for up to $100 Million to Accelerate U.S. Leadership in Quantum Computing
D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, announced the execution of a definitive agreement with the U.S. Department of Commerce based on the previously announced Letter of Intent. D-Wave now has access to up to $100 million of U.S. CHIPS and Science Act funding.
Via Investor Brand Network · September 11, 2026
InvestorNewsBreaks – Nightfood Holdings Inc. (NGTF) Advances Service Robotics as Businesses Seek Greater Efficiency
Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, is positioning itself to capitalize on the growing shift toward service robotics, developing AI-powered systems designed to automate repeatable tasks across hospitality, pharmaceutical, laboratory and industrial environments. Its expanding portfolio—including BIM-E, TIM-E and LIM-E—is focused on improving labor efficiency, consistency, productivity and scalability while allowing employees to concentrate on higher-value work. The company is also pursuing opportunities in laboratory automation, pharmaceutical manufacturing and industrial applications, including a recently announced partnership with Jiun Jiang (JJ Enterprise) aimed at advancing AI infrastructure, semiconductor manufacturing automation and pharmaceutical robotics. Against a backdrop of labor shortages, rising operating costs and advances in AI technology, TechForce Robotics is emphasizing measurable business outcomes and return on investment, reflecting a broader enterprise trend toward intelligent automation platforms that can deliver tangible operational value.
Via Investor Brand Network · September 11, 2026
EV Sales Continued Their Surge in Portugal in August
Sales of electric cars kept climbing in Portugal last month, with battery-only models jumping 65.2% year-on-year in August to reach 5,079 units sold. This was enough to account for over a third of all passenger cars sold in the country’s showrooms that month.
Via Investor Brand Network · September 11, 2026
MiningNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Completes Skaergaard Bulk-Sampling Program, Advances Sarfartoq Fieldwork
Greenland Mines (NASDAQ: GRML) provided an update on its 2026 field programs at the Skaergaard palladium-platinum-gold project in East Greenland and Sarfartoq rare earth element project in West Greenland. At Skaergaard, the company completed its bulk-sample blasting program, collecting 104.8 tons of mineralized and host material from seven sites for large-scale and pilot-scale metallurgical test work at GTK Mintec in Finland, while also completing ground-penetrating radar surveys and advancing engineering, infrastructure, processing and waste-management studies. At Sarfartoq, Greenland Mines opened and fully manned its exploration camp following the Sept. 1 acquisition, completed a second year of environmental baseline fieldwork and launched geological and structural mapping focused on the ST1 resource zone and additional rare earth exploration targets.
Via Investor Brand Network · September 11, 2026
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Integrates Tools, Training and AI for Modern Public Safety
Wrap Technologies (NASDAQ: WRAP) is developing an integrated public safety platform that combines non-lethal response tools, immersive training, evidence management and policy frameworks. At the center is the BolaWrap 150, a remote restraint device designed to help officers respond to non-compliant individuals while maintaining distance, supported by Wrap Reality VR training, Wrap Tactics digital instruction and Wrap Vision evidence management. The company is expanding its platform with AI-enabled WrapShield, designed to integrate sensing, threat detection, decision support, command-and-control and graduated response, initially targeting counter-unmanned aircraft applications. With its technology reportedly deployed by more than 1,000 law enforcement agencies across 60-plus countries, Wrap is positioning itself around what CEO Scot Cohen describes as the need for “a unified system that brings together sensing, AI, command-and-control, and graduated, accountable response.”
Via Investor Brand Network · September 11, 2026
InvestorNewsBreaks – Stewards, Inc. (NASDAQ: SWRD) Receives Approval to Uplist to Nasdaq Capital Market
Stewards (NASDAQ: SWRD),a diversified financial platform spanning private credit, real assets and technology-enabled financial infrastructure, received approval from the Listing Qualifications Department of The Nasdaq Stock Market LLC to list its common stock on the Nasdaq Capital Market. The company said its shares will begin trading under the existing “SWRD” ticker through a direct uplisting, with no concurrent public offering or issuance of new shares. Stewards’ private credit platform has originated more than $153 million in cumulative direct and syndicated funding across more than 10,000 small businesses since 2020, while the company has also expanded into income-producing real assets and continues to invest in technology and automation.
Via Investor Brand Network · September 11, 2026
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial on Lucid-MS Phase 2 Trial
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
Via Investor Brand Network · September 11, 2026
Gold Could Retreat Further as Momentum Fades, WGC Says
The latest insights from the World Gold Council suggest that gold prices may face additional downside as the current momentum diminishes. This outlook comes amid conflicting signals from the U.S. Treasury Department and the Federal Reserve, which have created a complex environment for the precious metal.
Via Investor Brand Network · September 9, 2026
InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Strengthens Liquidity, Cuts Monthly Cash Burn Nearly 30% Under New Management
FingerMotion (NASDAQ: FNGR) reported improvements completed during the first 30 days under new management, including approximately $5.1 million in cash and cash equivalents, a nearly 30% reduction in monthly cash burn and termination of its at-the-market issuance sales agreement with R.F. Lafferty & Co. The improved cash position reflects recent financing activity, including a registered direct offering completed Aug. 31, along with tighter working-capital management. The company said it is continuing to pursue cost and process improvements while reallocating resources toward its North American enterprise compute strategy.
Via Investor Brand Network · September 11, 2026
BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Reports First Half 2026 Results, Advances GelrinC(R) Pivotal Trial
Regentis Biomaterials (NYSE American: RGNT), a regenerative medicine company focused on innovative tissue repair solutions, reported financial results for the six months ended June 30, 2026 and provided a corporate and clinical update. The company has recruited and treated 43 of 80 patients in its pivotal Phase III GelrinC(R) U.S. trial and now expects to complete enrollment around year-end. Regentis also expanded its U.S. and European clinical networks, advanced preparations for European commercialization and received regulatory approval in Europe for a new solvent-free manufacturing process that increases GelrinC(R) production yield by 400%. For the first half, Regentis reported a net loss of approximately $2.6 million, or $0.44 per share, compared with approximately $3.2 million, or $1.17 per share, a year earlier. The company completed a $6.5 million private placement in June and ended the period with approximately $9 million in cash and cash equivalents and no debt.
Via Investor Brand Network · September 11, 2026
Frontieras North America Inc. Puts Mason County at Center of Coal Workforce Revival
A domestic energy project only strengthens the country if it first strengthens the community that builds it. In Point Pleasant, West Virginia, that is the promise behind Frontieras North America and its FASForm coal facility, a project the company says will bring approximately 200 full-time jobs and roughly 2,000 construction positions to Mason County.
Via Investor Brand Network · September 11, 2026
Cheaper Drones Are Exposing a New Weakness in Counter-UAS Defense
Drones have become an increasingly important tool in modern military operations, providing intelligence, surveillance and strike capabilities while reducing the need to put personnel directly in harm’s way. As these systems have become more accessible and sophisticated, however, they have also created a growing challenge for the technologies designed to stop them.
Via Investor Brand Network · September 11, 2026
AINewsBreaks – Vertical Data Inc. (OTCQB: VDTA) Enters Definitive Agreement to Acquire 4.5 MW Data Center Site in Sweden
Vertical Data (OTCQB: VDTA), a vertically integrated AI infrastructure company providing GPU financing, AI hardware, sovereign cloud and edge data center solutions, entered into a definitive purchase agreement through its majority-owned Vertical Data Nordic AB to acquire an existing industrial data center site with 4.5 MW of power capacity in Sollefteå Municipality in Central Sweden. If the transaction proceeds, Vertical Data intends to continue pursuing an application for up to 100 MW of total power capacity to build out an AI data center facility. The company said the project is among several in an active conversion pipeline representing more than 250 MW of global data center opportunities. Closing is anticipated in the next several weeks and remains subject to financing, corporate approvals, applicable regulatory clearances and other closing conditions.
Via Investor Brand Network · September 11, 2026
China Rejects US Accusations of Large-Scale Theft of AI
China has issued a strongly worded statement rejecting accusations by the United States that Chinese tech companies are stealing American AI on an industrial scale. The rebuff was issued on Wednesday.
Via Investor Brand Network · September 11, 2026
Renewable Energy, Storage Help Fix Longstanding US Grid Challenge
America’s power grid has spent years buckling under extreme summer heat and climbing demand, forcing operators across the country to lean on rolling blackouts and conservation warnings just to get through peak season. Renewable energy and battery storage now have the potential to close that gap in ways that have already been demonstrated in Texas.
Via Investor Brand Network · September 11, 2026
Crypto Transactions Approach $350B in MENA Region
Saudi Arabia is rapidly emerging as one of the Middle East and North Africa’s (MENA) most dynamic crypto markets, with transaction activity expanding far faster than in several of the region’s better-known digital asset centers.
Via Investor Brand Network · September 11, 2026
Trump on Collision Course with Voters as Most Americans Oppose Data Centers
President Donald Trump is facing growing opposition from American voters over the rapid spread of artificial intelligence data centers. A recent NBC News Decision Desk Poll established that 69 percent of survey participants oppose building AI data centers within their local areas, including 45% who strongly oppose the idea.
Via Investor Brand Network · September 11, 2026
Study Highlights the Continuing Importance of Gold-Silver Ratio
A recent study highlighted in the Silver Institute ’s latest report suggests that the gold-to-silver ratio is still a useful indicator for assessing silver’s potential price direction, despite claims that the measure has become outdated.
Via Investor Brand Network · September 11, 2026
Rising Rates of the Uninsured Could Affect Every American
As more Americans become underinsured or uninsured as a result of rising health insurance premiums and the several changes that were passed in the Big Beautiful Act, the impacts of the rising numbers of the uninsured are likely to be felt by every American . Several healthcare professionals have sounded the alarm on this brewing issue.
Via Investor Brand Network · September 11, 2026
Reports That OpenAI Agents Hacked a German Website Emerge
A group of AI agents linked to OpenAI allegedly took over a German-language website earlier this year, using it as a public forum to exchange information, evade restrictions and coordinate their activities, according to newly released research.
Via Investor Brand Network · September 11, 2026
BioMedNewsBreaks — Nanox Imaging Ltd. (NASDAQ: NNOX) Signs Nanox.ARC Distribution Agreement for Costa Rica
Nanox (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (“CCSS”), the country principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration, and Costa Rica represents Nanox third Latin American market this year following Argentina and Peru.
Via Investor Brand Network · September 11, 2026
Greenland Mines Ltd. (NASDAQ: GRML) Key Points to Watch Include Rare Earths Closing, Drill Results and Growing AnorTech Stake
Every small-cap mining stock eventually reaches a stretch where several catalysts line up in close succession. That stretch turns a quiet chart into something worth watching closely. For Greenland Mines (NASDAQ: GRML) that stretch is now. Four items are converging: the close of its rare earths acquisition following government approval, the end of a live Arctic drilling season, a pending resource update and an option that could nearly double a strategic equity stake.
Via Investor Brand Network · September 11, 2026
TechMediaBreaks – Vertical Data Inc. (OTCQB: VDTA) Enters Definitive Agreement to Acquire 4.5 MW Data Center Site in Sweden
Vertical Data (OTCQB: VDTA), a vertically integrated AI infrastructure company providing GPU financing, AI hardware, sovereign cloud and edge data center solutions, entered into a definitive purchase agreement through its majority-owned Vertical Data Nordic AB to acquire an existing industrial data center site with 4.5 MW of power capacity in Sollefteå Municipality in Central Sweden. If the transaction proceeds, Vertical Data intends to continue pursuing an application for up to 100 MW of total power capacity to build out an AI data center facility. The company said the project is among several in an active conversion pipeline representing more than 250 MW of global data center opportunities. Closing is anticipated in the next several weeks and remains subject to financing, corporate approvals, applicable regulatory clearances and other closing conditions.
Via Investor Brand Network · September 11, 2026
NetworkNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Names John Tattory Interim CFO Following Tom Fitzgerald Retirement
TransCode Therapeutics (NASDAQ: RNAZ) a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, announced the retirement of Chief Financial Officer Tom Fitzgerald, who has served in the role since July 2018 and will resign as CFO and a director effective immediately while continuing to provide transition services. The company named John Tattory interim CFO, effective immediately. Tattory has more than 25 years of financial and operational management and leadership experience across pharmaceutical, medical device and biotechnology companies, including roles at Ernst & Young LLP, Bristol-Myers Squibb, Tyco International, Cerapedics and Windtree Therapeutics. He currently serves as a managing director at Stout Risius Ross, where he provides consulting CFO services primarily to privately held life science companies.
Via Investor Brand Network · September 11, 2026
Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
A knee that once carried a runner through marathons or a hiker up a steep mountainside can be sidelined by a single defect in cartilage. More broadly, nearly a half-million Americans end up with knee cartilage damage each year as a result of long-term wear and tear and every-day accidents. For decades, many available treatments have focused on managing pain and restoring functions rather than actually replacing damaged cartilage with healthy tissue. Regentis Biomaterials (NYSE American: RGNT) is pursuing a different approach with GelrinC, an off-the-shelf hydrogel implant designed to support the regeneration of cartilage within the damaged area.
Via Investor Brand Network · September 11, 2026
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Publishes Third Autonomous Security Force Field Brief Ahead of GSX 2026
Knightscope (NASDAQ: KSCP), the security technology company building the nation’s first Autonomous Security Force, published “The Security Agent,” the third field brief in its series, ahead of the Force’s live debut at GSX 2026, Sept. 14-16 in Atlanta. The brief argues that the security guard industry’s traditional headcount model creates fragmented responsibility and presents an alternative centered on licensed, vetted and trained Security Agents who act on information verified by machines and Mission Intelligence. It outlines five forms of the role — Unarmed Security Agent, Armed Security Agent, Embedded Security Agent, Augmented Security Agent and Augmented Field Agent — all operating under a three-part code focused on owning outcomes, serving as the human in the loop and answering the call. Knightscope said its Security Agents occupy the physical-response layer within ASF-7, its seven-level escalation model. The company serves 434 clients across 42 states, with its machines logging more than 4.4 million autonomous hours to date.
Via Investor Brand Network · September 11, 2026
TechMediaBreaks – FingerMotion Inc. (NASDAQ: FNGR) to Acquire 9.9 MW Alberta Power Generation and Compute Site
FingerMotion (NASDAQ: FNGR) entered into a binding memorandum of understanding to acquire land rights and permitting for a 9.9 megawatt behind-the-meter power generation and compute site in the County of Newell, Alberta, approximately 185 kilometers southeast of Calgary. The site represents the first acquisition in the company’s planned Brooks Campus Zone, where FingerMotion intends to assemble separately owned and permitted 9.9 MW sites as demand for powered land develops. Adjacent to an operating third-party natural gas facility, the site is designed to generate and consume power behind the meter without requiring a grid interconnection request, transmission service arrangement or position in an interconnection queue. FingerMotion is targeting a fully permitted site within 120 days of release to work and plans to advance energization only against contracted demand backed by a take-or-pay agreement and funded customer deposit.
Via Investor Brand Network · September 10, 2026
BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Bolsters Scientific Leadership Ahead of BiTAC(R) Clinical Development
VERAXA Biotech (NASDAQ: VRXA) recently appointed antibody therapeutics specialist Dr. Christoph Erkel as its chief scientific officer, taking responsibility for advancing the company’s proprietary BiTAC(R) technology and broader oncology pipeline toward clinical development. The company’s lead BiTAC-TCE program uses a conditionally active, dual-targeting approach designed to selectively activate T cells against cancer cells while potentially limiting effects on healthy tissue. Recent scientific advice from Germany’s Paul-Ehrlich-Institute provided additional clarity around the program’s proposed non-clinical development strategy, while preclinical data presented at the AACR Annual Meeting showed selective activity against cells expressing both target molecules. Beyond BiTAC, VERAXA is developing bispecific antibody-drug conjugates and other engineered antibody therapies, positioning the company to pursue multiple approaches to next-generation cancer treatment.
Via Investor Brand Network · September 10, 2026
TechMediaBreaks – AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGZ) Receives $7.3 Million in Follow-On Orders for Asian 5G O-RAN Deployment
AmpliTech Group (NASDAQ: AMPG, AMPGZ) received approximately $7.3 million in follow-on orders supporting deployments for an Asian mobile network operator (“MNO”) under its previously announced 5G O-RAN radio Letter of Intent (“LOI”) program. The orders follow deployment of AmpliTech O-RAN radios at end-customer 5G sites and represent renewed purchasing activity under the program. The company said the orders, together with recently received follow-on orders supporting its North American MNO program, restore momentum under the LOI program and support its efforts to convert its opportunity pipeline into shipments and revenue.
Via Investor Brand Network · September 10, 2026
NetworkNewsBreaks – Earth Science Tech Inc.’s (ETST) B2B-B2C Healthcare Platform Powers Continued Revenue Growth
Earth Science Tech (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, combining compounding pharmacy, telemedicine, clinical support, and fulfillment capabilities. Its B2B and B2C business model allows the company to serve independent clinics while also selling customized medications directly to consumers, creating diversified revenue streams across physical and digital healthcare operations. In FY2026, ETST reported revenue of $35.7 million, up from $33.1 million in FY2025 and $11.95 million in FY2024, while also reporting positive operating cash flow and a stronger balance sheet. The company reduced total liabilities from $3.146 million to $1.928 million, increased assets from $7.066 million to $8.969 million, and fully repaid its long-term debt. ETST says it expects operating cash flow to fund its FY2027 needs without additional dilutive financing, highlighting its strategy of pursuing growth through internally generated cash rather than debt or shareholder dilution.
Via Investor Brand Network · September 10, 2026
InvestorNewsBreaks – Silver Bow Mining Corp. (NYSE American: SBMT) Receives Bankruptcy Court Approval, Completes Initial Closing for Jefferson County Metallurgical Complex
Silver Bow Mining (NYSE American: SBMT) announced that the U.S. Bankruptcy Court for the District of Montana approved the sale of specified Montana Tunnels Mining assets comprising the Jefferson County Metallurgical Complex to Silver Bow and its wholly owned subsidiary, Silver Bow Tunnels Corp. The company also completed the initial closing under its previously announced definitive asset purchase agreement after funding approximately $28.58 million into escrow to satisfy specified creditor obligations, including approximately $4.27 million owed to Jefferson County and $20.78 million in specified obligations to the Montana Department of Environmental Quality.
Via Investor Brand Network · September 10, 2026
SS Innovations International Inc. (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system.
Via Investor Brand Network · September 10, 2026
TechMediaBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Signs Merger Agreement with Deako to Expand Smart Home and AI Platform
SKYX Platforms (NASDAQ: SKYX) signed a merger agreement with Silicon Valley-backed smart home AI platform and intelligent lighting company Deako Inc., combining the companies plug-and-play technologies across ceiling outlets, wall outlets and wall switches. Deako has shipped more than 32 million units over the past five years, generated more than $26 million in revenue in 2025 and supplies more than 50 U.S. builders. SKYX said the combination is expected to accelerate deployment of its technologies through Deako builder footprint while creating opportunities for Deako products across SKYX hotel and development projects.
Via Investor Brand Network · September 10, 2026
AINewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) Launches Joint AI Trading Research Group with European Institute of Management
Perpetuals.com (NASDAQ: PDC) and the European Institute of Management (“EIM”) launched a joint research group pairing more than 20 doctoral researchers with Perpetuals to develop AI-powered trading models combining machine learning and crowd intelligence. The researchers will have access to Perpetuals proprietary trading datasets and live venue data, with work focused on behavioral finance, trader performance classification, market microstructure and model risk. The initiative is expected to run for at least three years, with more than half of the participating researchers currently employed by Perpetuals.
Via Investor Brand Network · September 10, 2026
InvestorNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Named to 2026 TSX30 Following 570% Share Price Increase
This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
Wrap Technologies Inc. (NASDAQ: WRAP) Broadens Public Safety Platform as Training, Technology and Response Capabilities Converge
Public safety technology is increasingly moving beyond individual products as organizations seek solutions that combine technology with training, situational awareness, real-world scenarios, and continuous professional development. Wrap Technologies (NASDAQ: WRAP) is positioning itself at the intersection of these capabilities as it works to expand its public safety platform across a broader range of applications.
Via Investor Brand Network · September 10, 2026
NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Plans Phase 2 Psilocybin Trial for Major Depressive Disorder
This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
InvestorNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Launches Overwatch Patrol for GPS-Denied Dismounted Operations
This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
Tariff Turmoil Drives Copper Prices to Record High
As the week got started, copper prices on the London Metal Exchange (LME) climbed to their highest-ever level as markets increasingly expected that President Trump would expand tariffs on imports to include refined copper.
Via Investor Brand Network · September 10, 2026
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
G7 Urges Crypto Industry to Switch to Post-Quantum Encryption
The Group of Seven (G7) is encouraging organizations to commence preparations for a future in which quantum computers could break the encryption used to protect digital systems. The warning, issued by the G7 working group on cybersecurity on Sept. 3, has important implications for the cryptocurrency industry, even though the report does not mention crypto directly.
Via Investor Brand Network · September 10, 2026
Tight Supply Drives Up Coal Prices on Global Markets
Coal prices rose across major international markets last week as coal supply disruptions met firm demand. The gains were particularly visible in Asia, where 5,500 NAR coal at Qinhuangdao moved above $120 a short ton. Lower inventories and tighter spot availability helped support the increase, while chemical and cement makers stepped up restocking ahead of a seasonal rise in production.
Via Investor Brand Network · September 10, 2026
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
BioMedWire Editorial Coverage: Today’s multiple sclerosis treatments can slow down disease progression, but none of them halt it outright, and none give back the function patients have already lost. Close to a million people in the United States, and nearly 2.9 million worldwide, live with that reality, watching a condition that steadily chips away at mobility, eyesight and basic physical control. That gap in treatment options just picked up a serious new contender. Quantum BioPharma Ltd. (NASDAQ: QNTM) ( Profile ) has received U.S. Food and Drug Administration (“FDA”) clearance to launch a phase 2 trial of Lucid-MS, a patented, first-in-class candidate designed not to calm the immune system but to shield, and potentially rebuild, the myelin sheath itself. The clearance sets up what would be the first time in history that a drug built on this exact mechanism gets tested in people living with MS, a milestone significant enough that it has already drawn a fresh buy rating from Wall Street analysts. That momentum puts Quantum BioPharma squarely among a group of leading pharma companies, including Novartis AG (NYSE: NVS), Merck & Co. Inc. (NYSE: MRK), TG Therapeutics Inc. (NASDAQ: TGTX) and Bristol-Myers Squibb Company (NYSE: BMY), that are focused on treating serious diseases and areas of major…
Via Investor Brand Network · September 10, 2026
InvestorNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Reports 79% Growth in SSi Mantra Procedures, Expands Global Reach
SS Innovations International (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Sept. 8, 2026, up 79% from 7,885 at year-end 2025, while its installed base increased 42% to 238 systems from 168. The SSi Mantra is now installed across 12 countries, approximately 1,500 physicians have been trained on the platform and the system has been used for more than 170 types of surgical procedures. Recent international milestones include the launch of robotic cardiac surgery in Colombia, installation of the first SSi Mantra in Sri Lanka and the first telesurgery within the Philippines.
Via Investor Brand Network · September 10, 2026
GreenEnergyBreaks — American Fusion Inc. (OTC: AMFN) Highlights Texatron(TM) Fusion Engine(TM) Development, AI Power Strategy in New Interview
American Fusion (OTC: AMFN) announced the release of a new AGORACOM interview featuring Executive Chairman Brent Nelson discussing development of the company proprietary Texatron(TM) Fusion Engine(TM) and its strategy for addressing growing electricity demand from artificial intelligence, data centers and other power-intensive applications. Nelson discusses the company 5 MW preproduction Texatron(TM), plans for 10 MW and 20 MW systems and Texas authorization to test 12 planned system sizes ranging from approximately 500 kW to 1 GW, while noting the ratings are intended system sizes and not demonstrated electrical output.
Via Investor Brand Network · September 10, 2026
Nightfood Holdings (NGTF) Expands AI Robotics Strategy as Labor Shortages Accelerate Automation Demand
Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics , is positioning itself among the several trends reshaping the global economy: persistent labor shortages, rising operating costs and accelerating adoption of AI-enhanced automation.
Via Investor Brand Network · September 10, 2026
NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Advances Montauban Commissioning as Key Processing Equipment Arrives
This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
TechMediaBreaks – SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) Advances Super Nova(TM) Modular Hybrid Quantum Computer
This article has been disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
BioMedNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in Morgan Stanley Global Healthcare Conference
This article has been disseminated on behalf of Helus Pharma and may include paid advertising.
Via Investor Brand Network · September 10, 2026
AINewsBreaks – Rezolve Ai (NASDAQ: RZLV) CEO to Participate at H.C. Wainwright Global Investment Conference, Company Sets Oct. 6 Investor Day
Rezolve Ai (NASDAQ: RZLV) announced that Founder and CEO Daniel M. Wagner will participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York City, scheduled for Sept. 14-16, 2026. The company will also host an Investor Day on Oct. 6 at Nasdaq MarketSite in New York City, where it will present its agentic commerce business and expanding AI infrastructure capabilities to investors and analysts, with attendance available in person and online.
Via Investor Brand Network · September 10, 2026
BioMedNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) CMO Discusses ONC010, Novel PNKP Target in BioMedWire Podcast
This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.
Via Investor Brand Network · September 10, 2026
American Fusion(TM) Inc. (AMFN) Moves Texatron(TM) Program Into More Demanding Test Phase as Harbinger Updates Coverage
American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, is entering a more consequential phase of its fusion program as recent testing updates coincide with new equity research coverage examining the company’s progress toward commercial validation.
Via Investor Brand Network · September 10, 2026
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
NetworkNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Appoints Billy Choi as Chief Financial Officer
This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.
Via Investor Brand Network · September 10, 2026
NetworkNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Urges SkyAI Shareholders to Oppose Equity Plan, Withhold Votes on Director Nominees
Forward Industries (NASDAQ: FWDI) issued an open letter to SkyAI shareholders outlining concerns about the company and urging shareholders to vote against SkyAI’s 2026 Equity Incentive Plan and withhold votes on each of its five director nominees at the Sept. 18, 2026, annual meeting. Forward cited SkyAI’s rejection of its June 15 all-stock acquisition proposal valued at $1.55 per share, which represented a 20% premium to SkyAI’s prior closing price, as well as concerns regarding related-party arrangements, financial performance and shareholder value. Forward said SkyAI’s proxy disclosed $3.3 million in 2025 consulting fees to Sol Edge Limited and warrants valued at approximately $101.3 million issued to Sol Markets, entities it said are owned and controlled by the brother of SkyAI Chief Investment Officer and director Yuwen (Alice) Zhang.
Via Investor Brand Network · September 9, 2026
How Earth Science Tech Inc. (ETST) Is Building a Self-Sustaining Business on Strategic Vertical Integration and Dual-Segment Targeting
Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, began the current fiscal year 2027 in a position of real financial strength, according to CEO and Board Chairman Giorgio R. Saumat letter to shareholders ( https://ibn.fm/NC6CW ). This position is the result of meaningful progress over the last several years, which built a business that is not only durable, self-sustaining, and positioned for long-term growth but also anchored in a conglomerate model, infrastructure as a service, and end-to-end vertical integration.
Via Investor Brand Network · September 9, 2026
RockBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Appoints Andrew Elinesky CEO, Advances Trafigura Due Diligence
This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.
Via Investor Brand Network · September 9, 2026
Greenland Mines Ltd. (NASDAQ: GRML) Completes Rare Earths Acquisition, Cementing Shift from Single Bet to Balanced Portfolio
Junior mining stocks live and die by a single number: The price of whatever metal sits beneath their flagship projects. When that price falls, so does the company, regardless of how good the geology is. It is a structural weakness baked into most explorers’ business models, and it explains why single-asset miners trade at a discount and swing wildly with commodity headlines. Greenland Mines (NASDAQ: GRML) is ensuring it doesn’t operate in that space, having transformed from a company built around one palladium-gold-platinum deposit into one that now also controls a major rare earths project, a shift that creates a different view for interested investors.
Via Investor Brand Network · September 9, 2026
InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference
Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, announced that CEO and Chairman John Yu, MD, will present a corporate overview in person at the H.C. Wainwright 28th Annual Global Investment Conference, taking place Sept. 14-16, 2026, at the Lotte New York Palace Hotel.
Via Investor Brand Network · September 9, 2026
InvestorNewsBreaks – Fairchild Gold (TSX-V: FAIR; OTCQB: FCHDF; Frankfurt: Y4Y) Engages TerraEye for Property-Wide Exploration Program at Golden Arrow
This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.
Via Investor Brand Network · September 9, 2026
Several Narratives Emerge to Explain the Recent Rogue AI Incidents
Recent weeks have seen the news dominated by reports of AI agents going rogue and hacking into sites and systems outside the controlled testing environments created by AI labs like OpenAI and Anthropic. The story of these rogue agents has taken on as many colors as the people narrating it, and we explore some of those narratives.
Via Investor Brand Network · September 9, 2026
Expert Flags Hidden Crisis in the Way UTIs Are Diagnosed
For many women, UTIs are something they routinely experience. These usually start as a burning sensation or a sudden urge to use the bathroom. For some, there is a sudden onset of discomfort that they just cannot ignore. While many receive a dose of antibiotics after being told what’s bothering them “is just a UTI,” several questions remain in the mind of the woman .
Via Investor Brand Network · September 9, 2026
EU Is Poised to Notch Wind Energy Record in 2026
Europe’s wind sector looks set for its best year yet, with 8.8 GW of fresh turbine capacity installed across H1 of 2026 alone, up roughly 30% from the same stretch a year earlier. That pace has WindEurope forecasting 24 gigawatts of new capacity for the full year. This could push the industry meaningfully closer to its stated ambition of adding close to 30 gigawatts annually once the 2030s arrive.
Via Investor Brand Network · September 9, 2026
EVs Could Become Niche Vehicles in the US as Sales Plummet
Electric vehicles are having a brutal stretch in the United States . Their share of the new-car market hit a record near 12% last September, right before a $7,500 federal EV incentive went away. By January that share had fallen to 6%, and Cox Automotive figures show sales dropped by a further 20% that month compared with December.
Via Investor Brand Network · September 9, 2026
Rising Treasury Yields Put Recent Bitcoin Rally Under Pressure
Bitcoin came under renewed pressure as last week ended, falling about 1.4% to roughly $77,000 after reaching around $77,500 earlier in the week. The decline erased a fraction of the crypto’s strong August performance, when it gained almost 25%.
Via Investor Brand Network · September 9, 2026
Australia Considers Requiring Social Media to Have Algorithm Opt-In Feature for Users
Australia is considering a major change to the way social media platforms use recommendation algorithms. The government is weighing whether users should have to actively choose to use these systems instead of having them switched on automatically when they create an account.
Via Investor Brand Network · September 9, 2026
US Calls for AI Deregulation at G20 Meeting, EU Favors Stronger Regulation
The U.S. and the European Union are taking increasingly different approaches to AI, with Washington pressing for lighter regulation while Brussels moves ahead with enforcement of its new rules.
Via Investor Brand Network · September 9, 2026
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO to Attend Inaugural Nasdaq LaB Biotech Summit
Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on Sept. 16, 2026, at Nasdaq MarketSite in New York. The summit will bring together biotechnology executives, investors and industry leaders for an evening of thought leadership and networking.
Via Investor Brand Network · September 9, 2026
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate in IPAC-RS 2026 Nasal Innovation Forum
Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, announced that company representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum, taking place Sept. 16-17, 2026, in Jersey City, New Jersey. CEO Eric Weisblum said the forum provides an opportunity to engage with experts in nasal drug development as Silo continues advancing SPC-15’s novel nose-to-brain approach to targeted drug delivery for the treatment of PTSD. Preclinical data showed that the SPC-15 formulation and device met predefined specifications for assay, impurities, pH and microbiological quality through nine months, while six-month accelerated stability data was consistent and aligned with long-term data.
Via Investor Brand Network · September 9, 2026
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
Via Investor Brand Network · September 9, 2026
Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Completes 2026 Field Exploration Program at Cameron Rare Earth Element Project
Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.
Via Investor Brand Network · September 9, 2026
RockBreaks – Nicola Mining Inc. (NASDAQ: NICM) (TSXV: NIM) (FSE: HLIA) Reports Treasure Mountain Mine in Better-Than-Anticipated Condition Ahead of Planned 2027 Restart
This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.
Via Investor Brand Network · September 9, 2026
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
Via Investor Brand Network · September 9, 2026